Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (711-720 of 777) with videos related to

Pageof 78
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2025
Prevalence of Fibrosis and Applicability of Lab-based Noninvasive Tests From Primary to Tertiary CareGeorg Semmler, Paul Thöne, Jan Embacher, et al.
Wiener Klinische Wochenschrift|October 17, 2025
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG)Mattias Mandorfer, Georg Semmler, Elmar Aigner, et al.
Journal of Lipid Research|September 25, 2008
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemiaAdelheid Kratzer, Marlene Buchebner, Thomas Pfeifer, et al.
Journal of Hepatology|May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasisMarion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
Wiener Klinische Wochenschrift|October 25, 2017
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)Thomas Reiberger, Andreas Püspök, Maria Schoder, et al.
Cell Metabolism|October 11, 2022
Leptin increases hepatic triglyceride export via a vagal mechanism in humansMatthäus Metz, Marianna Beghini, Peter Wolf, et al.
Hepatology (Baltimore, Md.)|October 18, 2021
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitisArun J Sanyal, Quentin M Anstee, Michael Trauner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2022
Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR TrialsVincent Wai-Sun Wong, Won Young Tak, George Boon Bee Goh, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver DiseaseBritt A Blokker, Monica Maijo, Marta Echeandia, et al.
Pageof 78

Showing results (711-720 of 777) with videos related to

Sort By:
Pageof 78
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2025
Prevalence of Fibrosis and Applicability of Lab-based Noninvasive Tests From Primary to Tertiary CareGeorg Semmler, Paul Thöne, Jan Embacher, et al.
Wiener Klinische Wochenschrift|October 17, 2025
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG)Mattias Mandorfer, Georg Semmler, Elmar Aigner, et al.
Journal of Lipid Research|September 25, 2008
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemiaAdelheid Kratzer, Marlene Buchebner, Thomas Pfeifer, et al.
Journal of Hepatology|May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasisMarion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
Wiener Klinische Wochenschrift|October 25, 2017
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)Thomas Reiberger, Andreas Püspök, Maria Schoder, et al.
Cell Metabolism|October 11, 2022
Leptin increases hepatic triglyceride export via a vagal mechanism in humansMatthäus Metz, Marianna Beghini, Peter Wolf, et al.
Hepatology (Baltimore, Md.)|October 18, 2021
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitisArun J Sanyal, Quentin M Anstee, Michael Trauner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2022
Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR TrialsVincent Wai-Sun Wong, Won Young Tak, George Boon Bee Goh, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver DiseaseBritt A Blokker, Monica Maijo, Marta Echeandia, et al.
Pageof 78